177 related articles for article (PubMed ID: 27558786)
1. Insight into Prodrugs of Quinolones and Fluoroquinolones.
Sharma PC; Piplani M; Mittal M; Pahwa R
Infect Disord Drug Targets; 2016; 16(3):140-161. PubMed ID: 27558786
[TBL] [Abstract][Full Text] [Related]
2. Carvacrol prodrugs as novel antimicrobial agents.
Marinelli L; Fornasari E; Eusepi P; Ciulla M; Genovese S; Epifano F; Fiorito S; Turkez H; Örtücü S; Mingoia M; Simoni S; Pugnaloni A; Di Stefano A; Cacciatore I
Eur J Med Chem; 2019 Sep; 178():515-529. PubMed ID: 31207463
[TBL] [Abstract][Full Text] [Related]
3. A prodrug approach toward the development of water soluble fluoroquinolones and structure--activity relationships of quinoline-3-carboxylic acids.
Baker WR; Cai S; Dimitroff M; Fang L; Huh KK; Ryckman DR; Shang X; Shawar RM; Therrien JH
J Med Chem; 2004 Sep; 47(19):4693-709. PubMed ID: 15341485
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, Characterization and Antimicrobial Evaluation of Lipid Based Norfloxacin Prodrug.
Sharma PC; Piplani M; Rajak H
Curr Drug Deliv; 2018 Feb; 15(2):219-226. PubMed ID: 27758690
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of an oral prodrug alalevonadifloxacin for the treatment of MRSA infection.
Bhawsar S; Kale R; Deshpande P; Yeole R; Bhagwat S; Patel M
Bioorg Med Chem Lett; 2021 Dec; 54():128432. PubMed ID: 34757217
[TBL] [Abstract][Full Text] [Related]
6. Water-soluble phosphate prodrugs of pleuromutilin analogues with potent in vivo antibacterial activity against Gram-positive pathogens.
Fu L; Jiang Z; Cai Z; Liu X; He H; Yang Y
Bioorg Med Chem Lett; 2009 Sep; 19(18):5407-10. PubMed ID: 19682897
[TBL] [Abstract][Full Text] [Related]
7. Antibacterial Prodrugs to Overcome Bacterial Resistance.
Jubeh B; Breijyeh Z; Karaman R
Molecules; 2020 Mar; 25(7):. PubMed ID: 32231026
[TBL] [Abstract][Full Text] [Related]
8. The Prodrug Approach: A Successful Tool for Improving Drug Solubility.
Jornada DH; dos Santos Fernandes GF; Chiba DE; de Melo TR; dos Santos JL; Chung MC
Molecules; 2015 Dec; 21(1):42. PubMed ID: 26729077
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological properties of A-71497: a prodrug of tosufloxacin.
Chu DT; Lico IM; Swanson RN; Marsh KC; Plattner JJ; Pernet AG
Drugs Exp Clin Res; 1990; 16(9):435-43. PubMed ID: 2100244
[TBL] [Abstract][Full Text] [Related]
10. Quinolone antibacterial agents. Synthesis and structure-activity relationships of a series of amino acid prodrugs of racemic and chiral 7-(3-amino-1-pyrrolidinyl)quinolones. Highly soluble quinolone prodrugs with in vivo pseudomonas activity.
Sanchez JP; Domagala JM; Heifetz CL; Priebe SR; Sesnie JA; Trehan AK
J Med Chem; 1992 May; 35(10):1764-73. PubMed ID: 1366133
[TBL] [Abstract][Full Text] [Related]
11. Aminoalkoxycarbonyloxymethyl Ether Prodrugs with a pH-Triggered Release Mechanism: A Case Study Improving the Solubility, Bioavailability, and Efficacy of Antimalarial 4(1
Monastyrskyi A; Brockmeyer F; LaCrue AN; Zhao Y; Maher SP; Maignan JR; Padin-Irizarry V; Sakhno YI; Parvatkar PT; Asakawa AH; Huang L; Casandra D; Mashkouri S; Kyle DE; Manetsch R
J Med Chem; 2021 May; 64(10):6581-6595. PubMed ID: 33979164
[TBL] [Abstract][Full Text] [Related]
12. [The history of the development and changes of quinolone antibacterial agents].
Takahashi H; Hayakawa I; Akimoto T
Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of brefeldin A sulfide derivatives as prodrug candidates with enhanced aqueous solubilities.
Argade AB; Devraj R; Vroman JA; Haugwitz RD; Hollingshead M; Cushman M
J Med Chem; 1998 Aug; 41(18):3337-46. PubMed ID: 9719586
[TBL] [Abstract][Full Text] [Related]
14. Action of antimicrobial peptides and their prodrugs on model and biological membranes.
Forde É; Shafiy G; Fitzgerald-Hughes D; Strömstedt AA; Devocelle M
J Pept Sci; 2018 Jul; 24(7):e3086. PubMed ID: 29799150
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and antimycobacterial activity of prodrugs of indeno[2,1-c]quinoline derivatives.
Upadhayaya RS; Shinde PD; Kadam SA; Bawane AN; Sayyed AY; Kardile RA; Gitay PN; Lahore SV; Dixit SS; Földesi A; Chattopadhyaya J
Eur J Med Chem; 2011 Apr; 46(4):1306-24. PubMed ID: 21334792
[TBL] [Abstract][Full Text] [Related]
16. A hypoxia-activated antibacterial prodrug.
Yeoh YQ; Horsley JR; Polyak SW; Abell AD
Bioorg Med Chem Lett; 2020 Jun; 30(11):127140. PubMed ID: 32247730
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological activity of the penem antibiotic MEN 10700 and its orally absorbed ester MEN 11505.
Arcamone FM; Altamura M; Perrotta E; Crea A; Manzini S; Poma D; Salimbeni A; Triolo A; Maggi CA
J Antibiot (Tokyo); 2000 Oct; 53(10):1086-95. PubMed ID: 11132952
[TBL] [Abstract][Full Text] [Related]
18. The 2-pyridone antibacterial agents: 8-position modifications.
Fung AK; Shen LL
Curr Pharm Des; 1999 Jul; 5(7):515-43. PubMed ID: 10438895
[TBL] [Abstract][Full Text] [Related]
19. To be drug or prodrug: structure-property exploratory approach regarding oral bioavailability.
Damião MC; Pasqualoto KF; Polli MC; Parise Filho R
J Pharm Pharm Sci; 2014; 17(4):532-40. PubMed ID: 25579432
[TBL] [Abstract][Full Text] [Related]
20. Chemical structure and pharmacokinetics of novel quinolone agents represented by avarofloxacin, delafloxacin, finafloxacin, zabofloxacin and nemonoxacin.
Kocsis B; Domokos J; Szabo D
Ann Clin Microbiol Antimicrob; 2016 May; 15(1):34. PubMed ID: 27215369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
